0 Комментарии
0 Поделились
459 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Flow Cytometry in Oncology Market Growth, Cancer Diagnostics and Cell Analysis Trends Forecast to 2033Introduction The flow cytometry in oncology market is witnessing strong growth due to the rising global burden of cancer and the increasing demand for precise, rapid, and multi-parameter cell analysis techniques. Flow cytometry is a powerful technology used to analyze the physical and chemical characteristics of cells or particles, enabling researchers and clinicians to detect cancer cells,...0 Комментарии 0 Поделились 232 Просмотры 0 предпросмотр
-
Haemeto Oncology Testing Market: NGS, PCR & Hematologic Malignancy Diagnostics 2033" Exactitude Consultancy That Adds Flavour To Your Success" Haemeto Oncology Testing Market size and forecast. NGS and PCR diagnostics for Leukemia, Lymphoma, and Myeloma across clinical laboratories. The global Haemeto Oncology Testing Market is projected to reach USD 4.12 Billion in 2026 and USD 10.45 Billion by 2033, growing at a 14.2% CAGR. If you're looking for insights into the...0 Комментарии 0 Поделились 78 Просмотры 0 предпросмотр
-
Harnessing Next-Generation Systems and Informatics: Examining China Companion Diagnostics Oncology Market TechnologyThe underpinning of the rapidly expanding companion diagnostics sector in China is a continuous leap in the sophistication and deployment of cutting-edge diagnostic platforms. The China Companion Diagnostics Oncology Market Technology landscape is currently dominated by an increasing penetration of Next-Generation Sequencing (NGS), which is fundamentally shifting testing from single-gene...0 Комментарии 0 Поделились 675 Просмотры 0 предпросмотр
-
HER2 Testing Market Witnessing Strong Opportunities in Oncology DiagnosticsAs of May 2026, the Human Epidermal Growth Factor Receptor 2 (HER2) Testing Market is undergoing a pivotal expansion. No longer confined to a binary "positive" or "negative" result, the industry is transitioning toward precision subtyping, including the identification of "HER2-low" populations. This shift is driven by the regulatory approval of advanced antibody-drug conjugates (ADCs) like...0 Комментарии 0 Поделились 107 Просмотры 0 предпросмотр
-
Kidney Cancer Diagnostics Market – Molecular Testing Expansion, Early Detection Focus & Oncology Accuracy"Detailed Analysis of Executive Summary Kidney Cancer Diagnostics Market Size and Share CAGR Value Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. Kidney Cancer Diagnostics Market research report is a great backbone for the expansion of Kidney...0 Комментарии 0 Поделились 626 Просмотры 0 предпросмотр
-
Oncology Based Molecular Diagnostics Market Set to Lead Industry Evolution by 2034Polaris Market Research has announced the latest report, namely U.S. Oncology Based Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Technology, By Type – Market Forecast, 2025–2034, that examines the overall market condition both now and in the future. It provides comprehensive and accurate research on...0 Комментарии 0 Поделились 665 Просмотры 0 предпросмотр
-
Therapeutics vs. Diagnostics and Breast Cancer Dominance: A Deep Dive into Precision Oncology Market AnalysisThe Precision Oncology Market Analysis confirms that the market operates on two interconnected components: Therapeutics and Diagnostics. The Therapeutics segment consistently holds the largest revenue share (often exceeding 70% in 2024), driven by the high cost and value of targeted drugs, immunotherapies, and cell & gene therapies. However, the Diagnostics segment (e.g., NGS, liquid...0 Комментарии 0 Поделились 599 Просмотры 0 предпросмотр
-
Global Nuclear Imaging Systems Market: Comprehensive Forecast to 2031The global healthcare landscape is witnessing a significant shift toward precision medicine, where molecular-level diagnostics play a pivotal role. The Nuclear Imaging Systems Market is a cornerstone of this transition, providing clinicians with the ability to visualize physiological processes within the body rather than just anatomical structures. By utilizing small amounts of...0 Комментарии 0 Поделились 244 Просмотры 0 предпросмотр
-
Immuno Oncology Assays Market: Cancer Testing" Exactitude Consultancy That Adds Flavour To Your Success" Immuno oncology assays Market insights. Checkpoint inhibitor testing and NGS for cancer treatment. The global Immuno Oncology Assays Market is projected to reach USD 4.85 Billion in 2026 and USD 11.20 Billion by 2033, growing at a 12.7% CAGR. If you're looking for insights into the Immuno Oncology Assays Market, you're in...0 Комментарии 0 Поделились 44 Просмотры 0 предпросмотр
-
Regional Insights: Growth of Molecular Testing in Asia-PacificThe global healthcare landscape is undergoing a profound paradigm shift, transitioning from conventional diagnostic methods to highly specific molecular-level analysis. Molecular diagnostics involves the detection of specific sequences in DNA or RNA to identify diseases, assess risk, or monitor patient response to therapies. This field has become the backbone of modern clinical practice,...0 Комментарии 0 Поделились 176 Просмотры 0 предпросмотр
-
What Barriers and Opportunities Exist in the Middle East and Africa Prostate Cancer Diagnostics Market?Detailed Analysis of Executive Summary Middle East and Africa Prostate Cancer Diagnostics Market Size and Share CAGR Value The prostate cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.9% in the forecast period of 2021 to 2028 and is expected to reach...0 Комментарии 0 Поделились 604 Просмотры 0 предпросмотр
-
What Diagnostic Advances Are Shaping the Asia-Pacific Prostate Cancer Diagnostics Market?Executive Summary Asia-Pacific Prostate Cancer Diagnostics Market Research: Share and Size Intelligence CAGR Value The prostate cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 15.1% in the forecast period of 2021 to 2028 and is expected to reach USD...0 Комментарии 0 Поделились 696 Просмотры 0 предпросмотр
-
What Trends Are Transforming the Tumor Markers Testing Market?Key Drivers Impacting Executive Summary Tumor Markers Testing Market Size and Share CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by...0 Комментарии 0 Поделились 455 Просмотры 0 предпросмотр
-
Why Does the North America Prostate Cancer Diagnostics Market Lead in Innovation?Comprehensive Outlook on Executive Summary North America Prostate Cancer Diagnostics Market Size and Share CAGR Value The prostate cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 12.9% in the forecast period of 2021 to 2028 and is expected to reach USD...0 Комментарии 0 Поделились 558 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek